Evidence map›Paper›PMID 37906361›Full record

ArticleJournal of fluorescence2024

Curcumin Analogue Spectral, Nonlinear Optical Properties and All-optical Switching Using Visible, Low Power Cw Laser Beams.

Fadhil A Tuma, M J Ashoor, H A Sultan, F A Al-Saymari, Qusay M A Hassan, Tahseen A Alsalim, C A Emshary, Bahjat A Saeed

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of fluorescence, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fadhil A TumaDepartment of Physics, College of Education for Pure Sciences, University of Basrah, Basrah, 61001, Iraq.
M J AshoorDepartment of Physics, College of Education for Pure Sciences, University of Basrah, Basrah, 61001, Iraq.
H A SultanDepartment of Physics, College of Education for Pure Sciences, University of Basrah, Basrah, 61001, Iraq.
F A Al-SaymariDepartment of Physics, College of Education for Pure Sciences, University of Basrah, Basrah, 61001, Iraq.
Qusay M A HassanDepartment of Physics, College of Education for Pure Sciences, University of Basrah, Basrah, 61001, Iraq. qusayali64@yahoo.co.in.
Tahseen A AlsalimDepartment of Chemistry, College of Education for Pure Sciences, University of Basrah, Basrah, 61001, Iraq.
C A EmsharyDepartment of Physics, College of Education for Pure Sciences, University of Basrah, Basrah, 61001, Iraq.
Bahjat A SaeedDepartment of Chemistry, College of Education for Pure Sciences, University of Basrah, Basrah, 61001, Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we conducted the synthesis and diagnosis of compound denoted as 1A3, specifically, (2E,4E,9E,11E)-7-chloro-2,12-diphenyltrideca-2,4,9,11-tetraene-6,8-dione. The photoluminescent and UV-vis spectral properties of this compound are investigated. The compound is dissolved in both chloroform and DMF for analysis purposes. Compound 1A3's nonlinear optical (NLO) characteristics when dissolved in DMF, are extensively studied through a series of experiments including diffraction patterns (DPs) and Z-scan. The optical limiting (OL) property of the 1A3 compound is tested and a threshold value of 12.4 mW at the wavelength 473 nm is obtained. Additionally, we explored its potential for all-optical switching utilizing two low-power visible laser beams. Notably, we achieved a significant nonlinear refractive index (NLRI) reaching up to 5.921 x 10

Indexed as

Curcumin analogueDiffraction patternsNonlinear opticsPhotoluminescenceZ-scan

Identifiers

PMID37906361

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.